Midas Pharma GmbH Liaison Office India
in Hyderabad, India.
We are present on the Indian market since April 2009. Our objective is to intensify existing contacts with Indian manufacturers of Active Pharmaceutical Ingredients and intermediates for pharmaceutical syntheses, build-up partnerships concerning the development of generic dossiers as well as expand our sales activities on the Indian market.
We want to enable our clients in Europe, USA and Japan to source intermediates, Active Pharmaceutical Ingredients and pharmaceutical specialities from reliable and technically competent manufacturers under the usual Midas transparency policy.
Our know-how regarding the requirements of the pharmaceutical markets in Europe, USA and Japan contributes to our success in creating long-term partnerships with selected and quality-conscious Indian manufacturers. A particular focus will be to select reliable Indian partners for tailor-made dossier developments and to offer high quality, price-competitive Finished Dosage Forms.
Our key asset is a strong local Regulatory Affairs and GMP team which being backed up by the Midas Headquarters is supporting our partners in fully complying with all latest quality and regulatory standards.
 |
